Determination of Cortisol Cut-off Limits and Steroid Dynamics in the ACTH Stimulation Test: a Comparative Analysis Using Roche Elecsys Cortisol II Immunoassay and LC-MS/MS

Overview

Journal Endocrine

Specialty Endocrinology

Date 2024 Mar 9

PMID 38460071

Authors

Sema Okutan

Nanna Thurmann Jorgensen

Lars Engers Pedersen

Stina Willemoes Borresen

Linda Hilsted

Lennart Friis Hansen

Ulla Feldt-Rasmussen

Marianne Klose

Affiliations

Soon will be listed here.

Abstract

Purpose: Measurement of cortisol concentrations is method dependent. The study aimed to establish assay-specific cut-off limits for cortisol after adrenocorticotropic hormone (ACTH) stimulation, comparing Roche Elecsys Cortisol II immunoassay to liquid chromatography-mass spectrometry (LC-MS/MS), and to assess the impact of patient characteristics, estrogen containing oral contraceptives as well as relation to other adrenocortical steroid hormone dynamics.

Methods: One hundred healthy participants underwent a 250 μg ACTH-test, with plasma samples analyzed using ElecsysCortI, ElecsysCortII, and LC-MS/MS. Cortisone, corticosterone, 17-OH-progesterone, dehydroepiandrosterone sulfate (DHEAS), androstenedione, and testosterone were additionally analyzed with LC-MS/MS. Cut-off limit for a normal cortisol response to the ACTH-test was defined as: 2.5th percentile-1.96 × SE.

Results: ElecsysCort II measured cortisol concentrations 21% (95% CI: 19-22%) lower than ElecsysCort I. Cut-off limits for cortisol 30 and 60 min after ACTH were 426 and 485 nmol/L (ElecsysCort II) and 411 and 470 nmol/L (LC-MS/MS). Cut-offs were unaffected by gender, or body-composition. The ACTH-test resulted in significantly increased adrenocortical steroid hormones, except for decreased cortisone concentrations (both sexes), and decreased testosterone in men (1.9 nmol/L, 95% CI: 1.3-2.5). Testosterone was increased in women (0.07 nmol/L, 95% CI: 0.02-0.13).

Conclusion: ElecsysCort II has high analytical performance and yields significantly lower cortisol concentrations than prior polyclonal immunoassays. This clinically relevant difference underscores the necessity for revised cut-off limits for improved diagnostic precision. Suggested 30-minute cortisol cutoff limits are 411 nmol/L (LC-MS/MS) and 426 nmol/L (ElecsysCort II). Adrenocortical steroids increased upon ACTH stimulation, except for cortisone in both sexes and testosterone in men, both of which decreased.

Citing Articles

The multiple faces of autoimmune Addison's disease in children.

Capalbo D, Esposito A, Gaeta V, Lorello P, Vasaturo S, Di Mase R Front Endocrinol (Lausanne). 2024; 15:1411774.

PMID: 39351530 PMC: 11439687. DOI: 10.3389/fendo.2024.1411774.

References

LAUDAT M, Cerdas S, Fournier C, Guiban D, Guilhaume B, LUTON J . Salivary cortisol measurement: a practical approach to assess pituitary-adrenal function. J Clin Endocrinol Metab. 1988; 66(2):343-8. DOI: 10.1210/jcem-66-2-343. View

Pasquali R, Gagliardi L, Vicennati V, Gambineri A, Colitta D, Ceroni L . ACTH and cortisol response to combined corticotropin releasing hormone-arginine vasopressin stimulation in obese males and its relationship to body weight, fat distribution and parameters of the metabolic syndrome. Int J Obes Relat Metab Disord. 1999; 23(4):419-24. DOI: 10.1038/sj.ijo.0800838. View

Boonen E, Vervenne H, Meersseman P, Andrew R, Mortier L, Declercq P . Reduced cortisol metabolism during critical illness. N Engl J Med. 2013; 368(16):1477-88. PMC: 4413428. DOI: 10.1056/NEJMoa1214969. View

Kline G, Buse J, Krause R . Clinical implications for biochemical diagnostic thresholds of adrenal sufficiency using a highly specific cortisol immunoassay. Clin Biochem. 2017; 50(9):475-480. DOI: 10.1016/j.clinbiochem.2017.02.008. View

Grassi G, Morelli V, Ceriotti F, Polledri E, Fustinoni S, DAgostino S . Minding the gap between cortisol levels measured with second-generation assays and current diagnostic thresholds for the diagnosis of adrenal insufficiency: a single-center experience. Hormones (Athens). 2020; 19(3):425-431. PMC: 7426310. DOI: 10.1007/s42000-020-00185-y. View

Thorneycroft I, Mishell Jr D, Stone S, Kharma K, Nakamura R . The relation of serum 17-hydroxyprogesterone and estradiol-17-beta levels during the human menstrual cycle. Am J Obstet Gynecol. 1971; 111(7):947-51. DOI: 10.1016/0002-9378(71)90951-3. View

Cho H, Kim J, Kim S, Shin C, Park K, Kim S . Different cut-off values of the insulin tolerance test, the high-dose short Synacthen test (250 μg) and the low-dose short Synacthen test (1 μg) in assessing central adrenal insufficiency. Clin Endocrinol (Oxf). 2014; 81(1):77-84. DOI: 10.1111/cen.12397. View

Vogeser M, Zachoval R, Felbinger T, Jacob K . Increased ratio of serum cortisol to cortisone in acute-phase response. Horm Res. 2002; 58(4):172-5. DOI: 10.1159/000065486. View

Pasquali R, Cantobelli S, Casimirri F, Capelli M, Bortoluzzi L, Flamia R . The hypothalamic-pituitary-adrenal axis in obese women with different patterns of body fat distribution. J Clin Endocrinol Metab. 1993; 77(2):341-6. DOI: 10.1210/jcem.77.2.8393881. View

10.

Abdu T, Elhadd T, Neary R, Clayton R . Comparison of the low dose short synacthen test (1 microg), the conventional dose short synacthen test (250 microg), and the insulin tolerance test for assessment of the hypothalamo-pituitary-adrenal axis in patients with pituitary disease. J Clin Endocrinol Metab. 1999; 84(3):838-43. DOI: 10.1210/jcem.84.3.5535. View

11.

Zha L, Li J, Mallika Krishnan S, Brennan M, Zhang Y, Povse P . New Diagnostic Cutoffs for Adrenal Insufficiency After Cosyntropin Stimulation Using Abbott Architect Cortisol Immunoassay. Endocr Pract. 2022; 28(7):684-689. DOI: 10.1016/j.eprac.2022.04.003. View

12.

Simsek Y, Karaca Z, Tanriverdi F, Unluhizarci K, Selcuklu A, Kelestimur F . A comparison of low-dose ACTH, glucagon stimulation and insulin tolerance test in patients with pituitary disorders. Clin Endocrinol (Oxf). 2014; 82(1):45-52. DOI: 10.1111/cen.12528. View

13.

Mancillas-Adame L, Sanchez-Garcia A, Rodriguez-Gutierrez R, Gonzalez-Velazquez C, Lavalle-Gonzalez F, Zuniga-Hernandez J . Low-Dose ACTH Stimulation Test in Obesity: A Randomized Dose Assessment. Int J Endocrinol. 2022; 2022:7860272. PMC: 9707648. DOI: 10.1155/2022/7860272. View

14.

Hawley J, Owen L, Lockhart S, Monaghan P, Armston A, Chadwick C . Serum Cortisol: An Up-To-Date Assessment of Routine Assay Performance. Clin Chem. 2016; 62(9):1220-9. DOI: 10.1373/clinchem.2016.255034. View

15.

Raverot V, Richet C, Morel Y, Raverot G, Borson-Chazot F . Establishment of revised diagnostic cut-offs for adrenal laboratory investigation using the new Roche Diagnostics Elecsys Cortisol II assay. Ann Endocrinol (Paris). 2016; 77(5):620-622. DOI: 10.1016/j.ando.2016.05.002. View

16.

Husni H, Abusamaan M, Dinparastisaleh R, Sokoll L, Salvatori R, Hamrahian A . Cortisol values during the standard-dose cosyntropin stimulation test: Personal experience with Elecsys cortisol II assay. Front Endocrinol (Lausanne). 2022; 13:978238. PMC: 9433864. DOI: 10.3389/fendo.2022.978238. View

17.

Wade M, Baid S, Calis K, Raff H, Sinaii N, Nieman L . Technical details influence the diagnostic accuracy of the 1 microg ACTH stimulation test. Eur J Endocrinol. 2009; 162(1):109-13. PMC: 2941345. DOI: 10.1530/EJE-09-0746. View

18.

Tordjman K, Jaffe A, Trostanetsky Y, Greenman Y, Limor R, Stern N . Low-dose (1 microgram) adrenocorticotrophin (ACTH) stimulation as a screening test for impaired hypothalamo-pituitary-adrenal axis function: sensitivity, specificity and accuracy in comparison with the high-dose (250 microgram) test. Clin Endocrinol (Oxf). 2000; 52(5):633-40. DOI: 10.1046/j.1365-2265.2000.00984.x. View

19.

Klose M, Lange M, Rasmussen A, Skakkebaek N, Hilsted L, Haug E . Factors influencing the adrenocorticotropin test: role of contemporary cortisol assays, body composition, and oral contraceptive agents. J Clin Endocrinol Metab. 2007; 92(4):1326-33. DOI: 10.1210/jc.2006-1791. View

20.

Beitins I, Bayard F, KOWARSKI A, Migeon C . The effect of ACTH administration on plasma testosterone, dihydrotestosterone and serum LH concentrations in normal men. Steroids. 1973; 21(4):553-64. DOI: 10.1016/0039-128x(73)90044-5. View